Duplex sequencing identifies unique characteristics of ENU-induced mutations in male mouse germ cells
Germ cell mutagenicity testing is increasingly required for chemical risk assessment. Duplex sequencing is rapidly gaining acceptance as a method to assess in vivo mutagenesis, and as a valid alternative to transgenic rodent mutation models such as the MutaMouse. We used a duplex sequencing panel of 20 genomic targets and the transgenic rodent assay to measure mutations in the germ cells of MutaMouse males exposed to 0, 1, 2, or 5 mg/kg N-ethyl-N-nitrosourea for 28 days. Germ cells from the seminiferous tubules were collected 28 days post-exposure. The transgenic rodent assay showed a significant increase in mutant frequencies at the high (P < 0.001) and medium (P = 0.01) N-ethyl-N-nitrosourea doses relative to controls, while duplex sequencing revealed a significant increase (P < 0.001) in N-ethyl-N-nitrosourea-induced mutations only at the high dose. Duplex sequencing mutation frequencies were lower in genic than in intergenic targets, suggesting a protective role for transcription-coupled repair. Interestingly, we observed several unique germ cell characteristics with respect to duplex sequencing data from rodent somatic tissues: 1) larger inter-animal variability in clonally expanded mutations that affects the ability to detect significant increases in mutation frequency; 2) a target on chromosome 2 showing much higher susceptibility to spontaneous and chemical-induced mutagenesis than other targets; and 3) a mutation spectrum consistent with that observed in the offspring of N-ethyl-N-nitrosourea-treated males but not with the spectrum in bone marrow of directly-exposed males. These results suggest that duplex sequencing is a promising approach for characterizing germ cell mutagenesis and that mutagenic mechanisms operating in germ cells differ from those in somatic tissues.
Authors
- Charles C. Valentine (ORCID: https://orcid.org/0000-0001-5630-7368)
- Matthew J. Meier (ORCID: https://orcid.org/0000-0001-8199-8754)
- Andrew Williams (ORCID: https://orcid.org/0000-0002-7637-7686)
- Gu Zhou
- Jesse J. Salk (ORCID: https://orcid.org/0000-0002-7804-0550)
- Francesco Marchetti (ORCID: https://orcid.org/0000-0002-9435-4867)
- Carole L. Yauk (ORCID: https://orcid.org/0000-0002-6725-3454)
- Danielle P M LeBlanc (ORCID: https://orcid.org/0000-0002-3847-8371)
Institutions
- Health Canada (CA)
- University of Ottawa (CA)
- University of Washington (US)
- Fulcrum Therapeutics (United States) (US)
- Blaze Bioscience (United States) (US)
- Ottawa University (US)
Publication Details
- Journal
- Biology of Reproduction
- Published
- 2025-02-12
- DOI
- https://doi.org/10.1093/biolre/ioaf029
- Citations
- 3
- Primary Topic
- Carcinogens and Genotoxicity Assessment
- Type
- article
- Field-Weighted Citation Impact
- 2.81
Funders
- Canada Research Chairs
- Health Canada